盆底困扰量表和盆底影响问卷中尿失禁相关量表的最小重要差异。
The minimum important differences for the urinary scales of the Pelvic Floor Distress Inventory and Pelvic Floor Impact Questionnaire.
作者信息
Barber Matthew D, Spino Cathie, Janz Nancy K, Brubaker Linda, Nygaard Ingrid, Nager Charles W, Wheeler Thomas L
机构信息
Obstetrics, Gynecology, and Women's Health Institute, Cleveland Clinic, Cleveland, OH, USA.
出版信息
Am J Obstet Gynecol. 2009 May;200(5):580.e1-7. doi: 10.1016/j.ajog.2009.02.007.
Abstract
OBJECTIVE
We sought to estimate the minimum important difference (MID) for the Urinary Distress Inventory (UDI), UDI-stress subscale of the Pelvic Floor Distress Inventory, and Urinary Impact Questionnaire (UIQ) of the Pelvic Floor Impact Questionnaire.
STUDY DESIGN
We calculated MID using anchor- and distribution-based approaches from a randomized trial for nonsurgical stress incontinence treatment. Anchors included a global impression of change, incontinence episodes from a urinary diary, and the Incontinence Severity Index. Effect size and standard error of measurement were the distribution methods used.
RESULTS
Anchor-based MIDs ranged from -22.4 to -6.4 points for the UDI, -16.5 to -4.6 points for the UDI-stress, and -17.0 to -6.5 points for the UIQ. These data were supported by 2 distribution-based estimates.
CONCLUSION
Reasonable estimates of MID are 11, 8, and 16 points for the UDI, UDI-stress subscale, and UIQ, respectively. Statistically significant improvements that meet these thresholds should be considered clinically important.
摘要
目的
我们试图评估盆底困扰问卷中的排尿困扰量表（UDI）、盆底困扰问卷的压力分量表（UDI-压力）以及盆底影响问卷中的排尿影响问卷（UIQ）的最小重要差异（MID）。
研究设计
我们采用基于锚定法和分布法，从一项非手术压力性尿失禁治疗的随机试验中计算MID。锚定指标包括整体变化印象、排尿日记中的尿失禁发作次数以及尿失禁严重程度指数。效应大小和测量标准误是所使用的分布方法。
结果
基于锚定法的MID，UDI为-22.4至-6.4分，UDI-压力为-16.5至-4.6分，UIQ为-17.0至-6.5分。这些数据得到了两种基于分布法的估计值的支持。
结论
UDI、UDI-压力分量表和UIQ的MID合理估计值分别为11分、8分和16分。达到这些阈值的具有统计学意义的改善应被视为具有临床重要性。
相似文献
1
The minimum important differences for the urinary scales of the Pelvic Floor Distress Inventory and Pelvic Floor Impact Questionnaire.盆底困扰量表和盆底影响问卷中尿失禁相关量表的最小重要差异。
Am J Obstet Gynecol. 2009 May;200(5):580.e1-7. doi: 10.1016/j.ajog.2009.02.007.
2
Minimum important difference for validated instruments in women with urge incontinence.有急迫性尿失禁的女性中，经验证的工具的最小重要差异。
Neurourol Urodyn. 2011 Sep;30(7):1319-24. doi: 10.1002/nau.21028. Epub 2011 May 11.
3
Responsiveness of the Pelvic Floor Distress Inventory and Pelvic Floor Impact Questionnaire in women undergoing treatment for pelvic floor disorders.盆底功能障碍治疗女性中盆底困扰量表和盆底功能影响问卷的反应性
Int Urogynecol J. 2013 Feb;24(2):213-21. doi: 10.1007/s00192-012-1827-7. Epub 2012 Jun 6.
4
Evaluation of the effect of pelvic floor muscle training (PFMT or Kegel exercise) and assisted pelvic floor muscle training (APFMT) by a resistance device (Kegelmaster device) on the urinary incontinence in women: a randomized trial.评价盆底肌训练（PFMT 或凯格尔运动）和阻力装置（凯格尔大师设备）辅助盆底肌训练（APFMT）对女性尿失禁的效果：一项随机试验。
Eur J Obstet Gynecol Reprod Biol. 2011 Nov;159(1):218-23. doi: 10.1016/j.ejogrb.2011.06.037. Epub 2011 Jul 7.
5
Psychometric evaluation of 2 comprehensive condition-specific quality of life instruments for women with pelvic floor disorders.针对盆底功能障碍女性的2种综合特定病情生活质量量表的心理测量学评估
Am J Obstet Gynecol. 2001 Dec;185(6):1388-95. doi: 10.1067/mob.2001.118659.
6
Randomized trial comparing efficacy of pelvic floor muscle training with a digital therapeutic motion-based device to standard pelvic floor exercises for treatment of stress urinary incontinence (SUV trial): An all-virtual trial design.随机对照试验比较基于数字治疗运动的盆底肌肉训练与标准盆底运动治疗压力性尿失禁的疗效（SUV 试验）：全虚拟试验设计。
Contemp Clin Trials. 2021 Jun;105:106406. doi: 10.1016/j.cct.2021.106406. Epub 2021 Apr 16.
7
Responsiveness of the Spanish Pelvic Floor Distress Inventory and Pelvic Floor Impact Questionnaires Short Forms (PFDI-20 and PFIQ-7) in women with pelvic floor disorders.西班牙盆底困扰量表和盆底影响问卷简表（PFDI-20和PFIQ-7）在盆底功能障碍女性中的反应性。
Eur J Obstet Gynecol Reprod Biol. 2015 Jul;190:20-5. doi: 10.1016/j.ejogrb.2015.03.029. Epub 2015 Apr 6.
8
The impact of short-term pelvic floor muscle training on the biomechanical parameters of the pelvic floor among patients with stress urinary incontinence: A pilot study.短期盆底肌训练对压力性尿失禁患者盆底生物力学参数的影响：一项初步研究。
Eur J Obstet Gynecol Reprod Biol. 2024 Nov;302:283-287. doi: 10.1016/j.ejogrb.2024.09.037. Epub 2024 Sep 25.
9
The minimum important difference for the International Consultation on Incontinence Questionnaire-Urinary Incontinence Short Form in women with stress urinary incontinence.压力性尿失禁女性中，国际尿失禁咨询委员会尿失禁简表的最小重要差异。
Neurourol Urodyn. 2015 Feb;34(2):183-7. doi: 10.1002/nau.22533. Epub 2013 Nov 23.
10
Pelvic floor symptoms improve similarly after pessary and behavioral treatment for stress incontinence.对于压力性尿失禁，子宫托治疗和行为治疗后盆底症状改善情况相似。
Female Pelvic Med Reconstr Surg. 2012 Mar-Apr;18(2):118-21. doi: 10.1097/SPV.0b013e31824a021d.
引用本文的文献
1
The Influence of Successful Apical Defect Repair in Laparoscopic Sacrocolpopexy on Quality of Sexual Life.腹腔镜骶骨阴道固定术中成功修复根尖缺损对性生活质量的影响。
Int Urogynecol J. 2025 Aug 5. doi: 10.1007/s00192-025-06198-8.
2
Vaginal lasers for treating stress urinary incontinence in women.用于治疗女性压力性尿失禁的阴道激光
Cochrane Database Syst Rev. 2025 Jul 25;7(7):CD013643. doi: 10.1002/14651858.CD013643.pub2.
3
Midurethral Sling vs OnabotulinumtoxinA in Females With Urinary Incontinence: The MUSA Randomized Clinical Trial.女性尿失禁患者中尿道中段吊带术与A型肉毒毒素治疗对比：MUSA随机临床试验
JAMA. 2025 Jun 3;333(21):1887-1896. doi: 10.1001/jama.2025.4682.
4
Evaluating the Effectiveness of Radiofrequency in Multimodal Physiotherapy for Postpartum Pelvic Pain: The RASDOP Protocol-A Mixed-Methods Study.评估射频在产后盆腔疼痛多模式物理治疗中的有效性：RASDOP方案——一项混合方法研究。
J Clin Med. 2025 Feb 23;14(5):1489. doi: 10.3390/jcm14051489.
5
Vaginal Erbium Laser Versus Pelvic Floor Muscle Training for Stress Urinary Incontinence: A Randomised Controlled Trial.阴道铒激光与盆底肌肉训练治疗压力性尿失禁的随机对照试验
Int Urogynecol J. 2025 Mar 13. doi: 10.1007/s00192-025-06091-4.
6
Composite Failure Associated With Sacrohysteropexy and Sacrocolpopexy With Supracervical Hysterectomy for Advanced Pelvic Organ Prolapse.晚期盆腔器官脱垂行骶骨子宫固定术和骶骨阴道固定术联合次全子宫切除术相关的复合性失败
Neurourol Urodyn. 2025 Feb;44(2):434-442. doi: 10.1002/nau.25640. Epub 2024 Dec 20.
7
Silicone Irregular Hexagon Pessary Versus Polyvinyl Chloride Ring Pessary for Pelvic Organ Prolapse: Randomised Controlled Trial.硅胶不规则六边形子宫托与聚氯乙烯环形子宫托治疗盆腔器官脱垂的随机对照试验
Int Urogynecol J. 2025 Feb;36(2):289-298. doi: 10.1007/s00192-024-05933-x. Epub 2024 Oct 4.
8
Posterior Tibial Nerve Stimulation With versus Without Mirabegron: A Randomized Controlled Trial.胫后神经刺激联合与不联合米拉贝隆治疗的随机对照试验。
Int Urogynecol J. 2024 Aug;35(8):1709-1717. doi: 10.1007/s00192-024-05835-y. Epub 2024 Aug 5.
9
Real-World Evidence From a Digital Health Treatment Program for Female Urinary Incontinence: Observational Study of Outcomes Following User-Centered Product Design.一项针对女性尿失禁的数字健康治疗项目的真实世界证据：以用户为中心的产品设计后的结果观察性研究。
JMIR Form Res. 2024 Jun 27;8:e58551. doi: 10.2196/58551.
10
The minimal important difference of patient-reported outcome measures related to female urinary incontinence: a systematic review.患者报告的与女性尿失禁相关的结局测量指标的最小临床重要差异：系统评价。
BMC Med Res Methodol. 2024 Mar 8;24(1):60. doi: 10.1186/s12874-024-02188-4.
本文引用的文献
1
Standard error of measurement as a valid alternative to minimally important difference for evaluating the magnitude of changes in patient-reported outcomes measures.测量标准误作为评估患者报告结局指标变化幅度时最小重要差异的有效替代指标。
J Clin Epidemiol. 2008 Apr;61(4):350-6. doi: 10.1016/j.jclinepi.2007.05.011. Epub 2007 Oct 15.
2
Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes.确定患者报告结局的反应性和最小重要差异的推荐方法。
J Clin Epidemiol. 2008 Feb;61(2):102-9. doi: 10.1016/j.jclinepi.2007.03.012. Epub 2007 Aug 3.
3
Non-surgical management of stress urinary incontinence: ambulatory treatments for leakage associated with stress (ATLAS) trial.压力性尿失禁的非手术治疗：压力性尿失禁相关漏尿的门诊治疗（ATLAS）试验
Clin Trials. 2007;4(1):92-101. doi: 10.1177/1740774506075237.
4
Bridging the gap: using triangulation methodology to estimate minimal clinically important differences (MCIDs).弥合差距：运用三角测量法估算最小临床重要差异（MCIDs）。
COPD. 2005 Mar;2(1):157-65. doi: 10.1081/copd-200050508.
5
Minimal clinically important differences in Incontinence Quality-of-Life scores in stress urinary incontinence.压力性尿失禁患者尿失禁生活质量评分的最小临床重要差异
Urology. 2006 Jun;67(6):1304-8. doi: 10.1016/j.urology.2005.12.006.
6
Responsiveness of the Pelvic Floor Distress Inventory (PFDI) and Pelvic Floor Impact Questionnaire (PFIQ) in women undergoing vaginal surgery and pessary treatment for pelvic organ prolapse.盆底功能障碍性疾病量表（PFDI）和盆底功能影响问卷（PFIQ）在接受阴道手术和子宫托治疗盆腔器官脱垂的女性中的反应性。
Am J Obstet Gynecol. 2006 May;194(5):1492-8. doi: 10.1016/j.ajog.2006.01.076.
7
Validity of the incontinence severity index: comparison with pad-weighing tests.尿失禁严重程度指数的有效性：与尿垫称重测试的比较。
Int Urogynecol J Pelvic Floor Dysfunct. 2006 Sep;17(5):520-4. doi: 10.1007/s00192-005-0060-z. Epub 2006 Mar 18.
8
Minimally important differences were estimated for the Functional Assessment of Cancer Therapy-Colorectal (FACT-C) instrument using a combination of distribution- and anchor-based approaches.采用基于分布和锚定的方法相结合，对癌症治疗功能评估-结直肠癌（FACT-C）工具的最小重要差异进行了估计。
J Clin Epidemiol. 2005 Dec;58(12):1241-51. doi: 10.1016/j.jclinepi.2005.07.008. Epub 2005 Oct 13.
9
Clinical significance of patient-reported questionnaire data: another step toward consensus.患者报告问卷数据的临床意义：迈向共识的又一步。
J Clin Epidemiol. 2005 Dec;58(12):1217-9. doi: 10.1016/j.jclinepi.2005.07.009. Epub 2005 Oct 13.
10
Estimating clinically significant differences in quality of life outcomes.评估生活质量结果中具有临床意义的差异。
Qual Life Res. 2005 Mar;14(2):285-95. doi: 10.1007/s11136-004-0705-2.
Zotero 插件